CD3E and colorectal carcinoma: Notably, further validation by FACS analysis reveals that CD3E, the lineage marker for T cells, showed consistent downregulated expression in the MLNs of MC38 CRC model compared to the downregulated expression by proteomics profiling (Fig. 6, D and E), suggesting a decrease of the T cell population.